BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dalal RS, McClure E, Marcus J, Winter RW, Hamilton MJ, Allegretti JR. COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:1730-1732.e2. [PMID: 33549869 DOI: 10.1016/j.cgh.2021.02.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Costantino A, Noviello D, Conforti FS, Aloi M, Armuzzi A, Bossa F, Ficari F, Leone S, Manguso F, Mocci G, Orlando A, Pironi L, Radice S, Rizzello F, Tongiorgi A, Costantino C, Vecchi M, Caprioli F. COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association. Inflamm Bowel Dis 2021:izab172. [PMID: 34259844 DOI: 10.1093/ibd/izab172] [Reference Citation Analysis]
2 Ferreiro-Iglesias R, Hernández-Camba A, Serrano Labajos R, Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M; Young Group of Geteccu, ACCU Spain. SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project. Gastroenterol Hepatol 2021:S0210-5705(21)00246-6. [PMID: 34453969 DOI: 10.1016/j.gastrohep.2021.08.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Giannini EG, Demarzo MG, Bodini G. Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease. J Crohns Colitis 2021;15:2142-3. [PMID: 34131716 DOI: 10.1093/ecco-jcc/jjab104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 James D, Jena A, Bharath PN, Choudhury A, Singh AK, Sebastian S, Sharma V. Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis. Dig Liver Dis 2022:S1590-8658(22)00210-9. [PMID: 35382972 DOI: 10.1016/j.dld.2022.03.005] [Reference Citation Analysis]
5 Shah S, Gui H, Chua PEY, Tan JB, Suen LK, Chan SW, Pang J. Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong. Vaccine 2022:S0264-410X(22)00381-4. [PMID: 35414417 DOI: 10.1016/j.vaccine.2022.03.062] [Reference Citation Analysis]
6 Papa A, Scaldaferri F, Vetrone LM, Neri M, Gasbarrini A, Lopetuso LR. How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists. Vaccines (Basel) 2021;9:248. [PMID: 33808983 DOI: 10.3390/vaccines9030248] [Reference Citation Analysis]
7 Walldorf J, von Arnim U, Schmelz R, Riesner-Wehner A, Michl P, Grunert PC, Stallmach A, Teich N, Reuken PA. SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire. Inflamm Bowel Dis 2021:izab150. [PMID: 34181021 DOI: 10.1093/ibd/izab150] [Reference Citation Analysis]
8 Wu X, Lin J, Buch H, Ding Q, Zhang F, Cui B, Ji G. The COVID-19 Vaccination Hesitancy Among the People With Inflammatory Bowel Disease in China: A Questionnaire Study. Front Public Health 2021;9:731578. [PMID: 34708016 DOI: 10.3389/fpubh.2021.731578] [Reference Citation Analysis]
9 Hayes B, Apputhurai P, Mikocka-Walus A, Barreiro-de Acosta M, Bernstein CN, Burgell R, Burisch J, Bennebroek Evertsz F, Ferreira N, Graff LA, Trindade IA, Gearry R, Lo B, Mokrowiecka A, Moser G, Petrik M, Stengel A, Knowles SR. Extending the Common Sense Model to Explore the Impact of the Fear of COVID-19 on Quality of Life in an International Inflammatory Bowel Disease Cohort. J Clin Psychol Med Settings 2021. [PMID: 34559331 DOI: 10.1007/s10880-021-09823-y] [Reference Citation Analysis]
10 Hudhud D, Caldera F, Cross RK. Addressing COVID-19 Vaccine Hesitancy in Patients with IBD. Inflamm Bowel Dis 2021:izab241. [PMID: 34559239 DOI: 10.1093/ibd/izab241] [Reference Citation Analysis]
11 Caldera F, Balzora S, Hayney MS, Farraye FA, Cross RK. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD. Inflamm Bowel Dis 2021:izab114. [PMID: 34013958 DOI: 10.1093/ibd/izab114] [Reference Citation Analysis]
12 Wang Y, Liu Y. Multilevel determinants of COVID-19 vaccination hesitancy in the United States: a rapid systematic review. Prev Med Rep 2021;:101673. [PMID: 34934611 DOI: 10.1016/j.pmedr.2021.101673] [Reference Citation Analysis]
13 Botwin GJ, Li D, Figueiredo J, Cheng S, Braun J, McGovern DPB, Melmed GY. Adverse Events After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease. Am J Gastroenterol 2021;116:1746-51. [PMID: 34047304 DOI: 10.14309/ajg.0000000000001342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Clarke K, Pelton M, Stuart A, Tinsley A, Dalessio S, Bernasko N, Williams ED, Coates M. COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease. Dig Dis Sci. [DOI: 10.1007/s10620-021-07377-5] [Reference Citation Analysis]
15 Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Boccieri ME, Firestine A, Kappelman MD, Long MD. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflamm Bowel Dis 2021:izab302. [PMID: 34871388 DOI: 10.1093/ibd/izab302] [Reference Citation Analysis]
16 Schell TL, Richard LJ, Tippins K, Russ RK, Hayney MS, Caldera F. High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01308-2. [PMID: 34896281 DOI: 10.1016/j.cgh.2021.12.013] [Reference Citation Analysis]
17 Caron B, Neuville E, Peyrin-Biroulet L. Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey. Dig Dis Sci 2021. [PMID: 33977419 DOI: 10.1007/s10620-021-07040-z] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Bhat S, Caldera F, Farraye FA. Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients. Vaccine 2021;39:6015-6. [PMID: 34493411 DOI: 10.1016/j.vaccine.2021.08.073] [Reference Citation Analysis]
19 Selim R, Wellens J, Marlow L, Satsangi JJ. SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy. Lancet Gastroenterol Hepatol 2021;6:989. [PMID: 34655528 DOI: 10.1016/S2468-1253(21)00347-2] [Reference Citation Analysis]
20 Duly K, Farraye FA, Bhat S. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations. Am J Health Syst Pharm 2021:zxab344. [PMID: 34455440 DOI: 10.1093/ajhp/zxab344] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Le Cosquer G, Grangeon L, Rivière P, Berger A, Zerbib F, Laharie D, Poullenot F. A single dedicated vaccination visit improves vaccination coverage of patients with inflammatory bowel disease. Therap Adv Gastroenterol 2022;15:175628482210828. [DOI: 10.1177/17562848221082879] [Reference Citation Analysis]